https://www.selleckchem.com/pr....oducts/Clofarabine.h
outcomes of treatment-naive patients with NSCLC. 18F-FDG PET/CT was superior to CTCs in the diagnosis of treatment-naive patients with NSCLC. The levels of CTCs in the peripheral blood were associated with tumor glucose metabolism in NSCLC. Metabolic parameters of 18F-FDG PET/CT and CTCs could separately predict the outcomes of treatment-naive patients with NSCLC. A [ F]AlF-labeled somatostatin receptor (SSTR) antagonist was developed for imaging of neuroendocrine neoplasms (NENs), evaluated and compared with [ Ga]Ga-DOTA-TATE. [ F]
Like
Comment
Share
